Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat

被引:13
作者
Huang, Yiping [1 ,2 ,3 ]
Jiang, Wei [1 ,2 ,3 ]
Wang, Yisheng [1 ,2 ,3 ]
Zheng, Yufang [4 ]
Cong, Qing [1 ,2 ,3 ]
Xu, Congjian [1 ,2 ,3 ,5 ]
机构
[1] Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai 200433, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[3] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
[4] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China
[5] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China
关键词
Ovarian cancer; Carcinogenesis; DMBA; Animal model; Rat; MOLECULAR PATHOGENESIS; CHEMICAL INDUCTION; SURFACE EPITHELIUM; CANCER; ORIGIN; MODEL; TUMORS; IMMUNOHISTOCHEMISTRY; INHIBIN; MARKER;
D O I
10.1186/1757-2215-5-21
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Ovarian cancer is predominant of epithelial cell origin and often present at an advanced stage with poor prognosis. Most animal models of ovarian carcinoma yield thecal/granulose cell tumors, rather than adenocarcinomas. The best reported induction rate of adenocarcinoma in rats is 10-45% by an ovarian implantation of 7, 12-dimethylbenz[a] anthracene (DMBA) coated silk suture. We provided an improved procedure to construct the model by the ovarian implantation of DMBA-coated cloth strip. Methods: A sterile suture (as S group) or a piece of cloth strip (as CS group) was soaked in DMBA before ovarian implantation in Wistar rats. Tumor size, incidence rate and pathological type were analyzed. Results: Ovarian tumors in rats of CS group were first noted at 16 wk post implantation and reached a cumulative incidence of 75% (96/128) at 32 wk, while the tumor incidence rate in S group at 32 wk was only 46.25% (37/80). The tumor size in CS group (3.63 +/- 0.89 cm) was larger than that of S group (2.44 +/- 1.89 cm) (P < 0.05). In CS group, there were only two types of tumor formed: adenocarcinoma (90/96) and sarcoma (6/96). While in S group, there were different types, including adenocarcinoma (21/37), squamous carcinoma (3/37), granulosa cell tumor (3/37), sarcoma (4/37), undifferentiated carcinoma with no adeno character (2/37), benign ovarian tumor (2/37), and malignant teratoma (1/37). Conclusion: The model in our study yields much higher incidence and specificity of epithelial derived tumors and showed histological similarities to human ovarian cancers, which would be more suitable for therapeutic research.
引用
收藏
页数:8
相关论文
共 30 条
[1]   The origin of ovarian cancer [J].
Ahmed, A. A. ;
Becker, C. M. ;
Bast, R. C., Jr. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (02) :134-136
[2]  
Atkins CD, 2010, NEW ENGL J MED, V363, P2371, DOI 10.1056/NEJMc1011061
[3]   The Origin of Ovarian Cancer - Is It Getting Clearer? [J].
Birrer, Michael J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16) :1574-1575
[4]   Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer [J].
Chien, Jeremy R. ;
Aletti, Giovanni ;
Bell, Debra A. ;
Keeney, Gary L. ;
Shridhar, Viji ;
Hartmann, Lynn C. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (05) :1117-1129
[5]   α-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors [J].
Choi, Youn Seok ;
Hoory, Talia ;
Monie, Archana ;
Wu, Annie ;
Connolly, Denise ;
Hung, Chien-Fu .
VACCINE, 2008, 26 (46) :5855-5863
[6]   INHIBIN AS A MARKER FOR OVARIAN-CANCER [J].
COOKE, I ;
OBRIEN, M ;
CHARNOCK, FM ;
GROOME, N ;
GANESAN, TS .
BRITISH JOURNAL OF CANCER, 1995, 71 (05) :1046-1050
[7]   Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture [J].
Crist, KA ;
Zhang, ZQ ;
You, M ;
Gunning, WT ;
Conran, PB ;
Steele, VE ;
Lubet, RA .
CARCINOGENESIS, 2005, 26 (05) :951-957
[8]   OVARIAN SURFACE EPITHELIUM AND HUMAN OVARIAN-CANCER [J].
DIETL, J ;
MARZUSCH, K .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1993, 35 (03) :129-135
[9]  
Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO
[10]  
2-6